Clarity Pharmaceuticals

Health Care · Biotechnology
Data updated Nov 22, 2026Full reportReport a mistake
Lately:4 news stories in 90 daysFollow changes →

Facts

as of Nov 22, 2026

Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.

Employees
11-50estimated range
Official records
Wikidata Q140045430
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Products

Products →

Clarity Pharmaceuticals has 11 clinical trials on record, 3 under way.

Clinical trials
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate …
phase 3 · under way · 220 participants · Prostate Cancer; Prostate Cancer Patients With Detectable PSA Following Prostat…
May 2025
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Pro…
phase 3 · under way · 383 participants · Prostate Cancer; Prostatic Neoplasms
Dec 2023
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing …
phase 2 · stopped or withdrawn · 4 participants · Prostatic Neoplasms; Castration-Resistant
Jun 2023
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

Clarity Pharmaceuticals: 24 research papers in five years.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Sources: the outlets named on each headline, each story once